This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ader J, Tack I, Durand D et al (1996) Renal functional reserve in kidney and heart transplant recipients. J Am Soc Nephrol 7:1145–1152
Akalin E, Murphy B (2001) Gene polymorphisms and transplantation. Curr Opin Immunol 13:572–576
Alexander SI, Fletcher JT, Nankivell B (2007) Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol 22:17–23
Alexander SI, Smith N, Hu M et al (2008) Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 358:369–374
American Society of Transplantation (2004) Cytomegalo-virus. Am J Transplant 4(Suppl. 10):51–58.
Andrassy J, Graeb C, Rentsch M et al (2005) mTOR inhibition and its effect on cancer in transplantation. Transplantation 80(Suppl. 1):S171–S174
Anglicheau DC, Legendre C, Thervet E (2004) Pharmacogenetics in solid organ transplantation: Present knowledge and future perspectives. Transplantation 78:311–315
Artz MA, Hilbrands LB, Borm G et al (2004) Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 19:2852–2857
Augustine JJ, Bodziak KA, Hricik DE (2007) Use of sirolimus in solid organ transplantation. Drugs 67: 369–391
Barratt TM, Niaudet P, Clinical Evaluation. In: Avner ED, Harmon WE, Niaudet P (2004) Pediatric Nephrology. Lippincott Williams & Wilkins, Philadelphia
Benseler V, McCaughan GW, Schlitt HJ et al (2007) The liver: A special case in transplantation tolerance. Semin Liver Dis 27:194–213
Bichet DC, Polyuria and Diabetes Insipidus. In: Seldin DW, Giebisch G (2000) The Kidney – Physiology and Pathophysiology. Lippincott Williams & Wilkins, Philadelphia
Bostom AD, Brown SS, Chavers BM et al (2002) Prevention of Post-transplant Cardiovascular Disease – Report andRecommendations of an Ad Hoc Group. Am J Transplant 2:491–500
Buell JF, Gross TG, Thomas MJ et al (2006) Malignancy in pediatric transplant recipients. Semin Pediatr Surg 15:179–187
Cattaneo D, Perico N, Remuzzi G (2004) From pharmacokinetics to pharmacogenomics: A new approach to tailor immunosuppressive therapy. Am J Transplant 4: 299–310
Chang A, Hingorani S, Kowalewska J et al (2007) Spectrum of renal pathology in hematopoietic cell transplantation: A series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2:1014–1023
Choy BY, Chan TM, Lai KN (2006) Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 6:2535–2542
Crew RJ, Radhakrishnan J, Cohen DJ et al (2005) De novo thrombotic microangiopathy following treatment with sirolimus: Report of two cases. Nephrol Dial Transplant 20:203–209
Daly AS, Xenocostas A, Lipton JH (2002) Transplantation-associated thrombotic microangiopthy: Twenty-two years later. Bone Marrow Transplant 30:709–715
Danovitch GM, Immunosuppressive Medications and Protocols for Kidney Transplantation. In: Danovitch GM (2005) Handbook of Kidney Transplantation. Lippincott Williams & Wilkins, Philadelphia
Dellinger R P, Levy MM, Carlet JM et al (2008) Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 36:296–327
Dudley CRK (2001) Treatment of Posttransplant Hypertension: ACE Is Trumped? Transplantation 72:1728–1729
Ekberg H, Tedesco-Silva H, Demirbas A et al (2007) Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357:2562–2575
Ellis D, Jaffe R, Green M et al (1999) Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 68:997–1003
Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601–2614
Frey N V, Tsai DE (2007) The management of posttransplant lymphoproliferative disorder. Med Oncol 24:125–136
Gras JM, Gerkens S, Beguin C et al (2008) Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: Clinical and pharmacoeconomic study in 50 children. Liver Transpl 14:469–477
Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715–2729
Harmon W, Meyers K, Inglefinger J et al (2006) Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol 17:1735–1745
Hellerstein S (1993) Fluid and electrolytes: Clinical aspects. Pediatr Rev 14:103–115
Hingorani S (2006) Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis and treatment. J Am Soc Nephrol 17:1995–2005
Hymes LC, Warshaw BL (2005) Sirolimus in pediatric patients: Results in the first 6 months post-renal transplant. Pediatr Transplant 9:520–522
Kawai T, Cosimi B, Spitzer TR et al (2008) HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358:353–361
Krieger NR, Emre S (2004) Novel immunosuppressants. Pediatr Transplant 8:594–599
Liptak P, Ivanyi B (2006) Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2:398–404
Manco-Johnson MJ, The Infant and Child with Thrombosis. In: Goodnight SH, Hathaway WE (1999) Disorders of Hemostasis and Thrombosis. McGraw-Hill, New York
McLeod BC (2002) Thrombotic microangiopathies in bone marrow and organ transplant patient. J Clin Apher 17:118–123
Midtvedt K, Hartmnn A, Foss A et al (2001) Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 72:1787–1791
Nagra A, Trompeter RS, Fernando ON et al (2004) The effect of heparin on graft thrombosis in pediatric renal allografts. Pediatr Nephrol 19:531–535
Nankivell BJ, Borrows RJ, Fung CL et al (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326–2333
Ojo AO, Held PJ, Port FK et al (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931–940
Olyaei AJ, deMattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: New insight and prevention strategies. Curr Opin Crit Care 7:384–9
Ponticelli C (2007) De novo thrombotic microangiopathy. An underrated complication of kidney transplantation. Clin Nephrol 67:335–340
Rifle G, Mouson C, Martin L et al (2005) Donor-specific antibodies in allograft rejection: Clinical and experimental data. Transplantation 79:S14–S18
Sarwal M, Pascual J (2007) Immunosuppression minimization in pediatric transplantation. Am J Transplant 7:2227–2235
Scandling JD, Busque S, Dejbakhsh-Jones S et al (2008) Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358:362–368
Schetz M (2007) Drug dosing in continuous renal replacement therapy: General rules. Curr Opin Crit Care 13:645–651
Shapiro R, Ellis D, Tan HP (2007) Alemtuzumab preconditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 7:2736–2738
Singh A, Stablein D, Tejani A (1997) Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 63:1263–1267
Starzl TE (2008) Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 358:407–411
Tönshoff B, Höcker B (2006) Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 10: 721–729
Tredger JM, Brown NW, Dhawan A (2006) Immunosuppression in pediatric solid organ transplantation: Opportunities, risks, and management. Pediatr Transplant. 10: 879–892
Truong LD, Barrios R, Androgue HE (2007) Acute antibody-mediated rejection of renal transplant: Pathogenetic and diagnostic considerations. Arch Pathol Lab Med 131:1200–1208
VanDeVoorde RG, Tiao G, Sheldon C et al (2007) Dysequilibrium syndrome in children after pre-emptive live donor renal transplantation. Pediatr Nephrol 22:1578 (abstract # 674)
Vaysberg M, Balatoni CE, Nepomuceno RR et al (2007) Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation 83:1114–1121
Wagenknecht DR, Becker DG, LeFor WM et al (1999) Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 68:241–246
Weber S, Tönshoff B (2005) Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: Clinical and genetic aspects. Transplantation 80(Suppl. 1): S128–S134
Zaltzmann JS (1996) Post-renal transplantation hyponatremia. Am J Kidney Dis 27:599–602
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Goebel, J. (2009). Renal Issues in Organ Transplant Recipients in the PICU. In: Kiessling, S.G., Goebel, J., Somers, M.J.G. (eds) Pediatric Nephrology in the ICU. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74425-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-540-74425-2_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74423-8
Online ISBN: 978-3-540-74425-2
eBook Packages: MedicineMedicine (R0)